PDS Biotechnology Files for $14 Million Offering

On 12/17/19 PDS Biotechnology filed the paperwork for a $13.8 million offering of its common stock. The New Brunswick, NJ based company is developing off-the-shelf cancer immunotherapies, based on its Versamune® platform. The company trades on NASDAQ under the symbol “PDSB.”